Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc.

PIRS
Pieris Pharmaceuticals, Inc.US flagNASDAQ Capital Market
13.60
USD
-2.51
- -
17.96MMarket Cap

Pieris Pharmaceuticals, Inc. (PIRS) Stock Splits

Learn about Pieris Pharmaceuticals, Inc.'s most recent 1-for-80 basis stock split on April 23, 2024. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about Pieris Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2024-04-23
Split Ratio: 1:80
Price Before Split: $0.15
Price After Split: $0.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 80.00 times fewer shares (a 1:80 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Pieris Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2024-04-231:80Yes$0.15$0.00

About Pieris Pharmaceuticals, Inc.

Company overview and industry information

Pieris Pharmaceuticals, Inc. (PIRS) operates in the Biotechnology industry. The recent 1-for-80 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Pieris Pharmaceuticals, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.